Free Trial

MiNK Therapeutics (INKT) SEC Filings & 10K Form

MiNK Therapeutics logo
$14.62 -0.29 (-1.95%)
Closing price 04:00 PM Eastern
Extended Trading
$14.62 +0.01 (+0.03%)
As of 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MiNK Therapeutics SEC Filings

DateFilerForm TypeView
08/14/2025
6:35 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025
6:00 AM
MiNK Therapeutics (Filer)
Form 424B5
07/15/2025
6:05 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
6:45 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
3:05 PM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Kadlec Robert Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
6:30 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
4:03 PM
MiNK Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2025
6:30 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
3:52 PM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:17 PM
MiNK Therapeutics (Filer)
Form DEF 14A
12/06/2024
4:09 PM
MiNK Therapeutics (Filer)
Form PRE 14A
12/03/2024
9:35 AM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:38 AM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:44 AM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
9:44 AM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:00 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:15 AM
MiNK Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:18 AM
Corvese Brian (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:22 AM
MiNK Therapeutics (Issuer)
WIINBERG ULF (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:23 AM
Behner Peter (Reporting)
MiNK Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:23 AM
MiNK Therapeutics (Issuer)
Ryan Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2024
11:15 PM
MiNK Therapeutics (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INKT) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners